Company intelligence / Profile preview

ChromoLogic

Monrovia, California, USAchromologic.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

ChromoLogic develops innovative biomedical solutions with a focus on point-of-care diagnostics, drug delivery systems, wound care, infectious disease treatment (including malaria), and telehealth. They have developed multiple R&D programs within the regenerative manufacturing industry and are advancing novel cell therapy platforms for broad applications from infectious diseases to cancer. No published clinical trial results or marketed products were identified

Therapeutic areas: OtherOncologyDermatologyInfectious Diseases
Modalities: Cell therapyDrug delivery device
Industry: Biotech

Drug pipeline

5 assets

CereTRec

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

BioFabUSA/ARMICollaborations with medical manufacturersAcademic institutionsGovernment agencies

Beyond the preview

Go deeper on ChromoLogic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChromoLogic.

Explore the full profile